Core Viewpoint - Ademi LLP is investigating Clear Channel for potential breaches of fiduciary duty and other legal violations related to its transaction with Mubadala Capital and TWG Global [1] Group 1: Transaction Details - Clear Channel stockholders will receive $2.43 per share in an all-cash transaction, valuing the company at an enterprise value of $6.2 billion [2] - Clear Channel insiders are set to receive substantial benefits as part of change of control arrangements [2] Group 2: Investigation Focus - The transaction agreement imposes significant penalties on Clear Channel for accepting competing bids, which may limit competing transactions unreasonably [3] - The investigation will assess whether the Clear Channel board of directors is fulfilling their fiduciary duties to all shareholders [3]

Core Viewpoint - Ademi LLP is investigating Webster for potential breaches of fiduciary duty and other legal violations related to its transaction with Banco Santander [1]. Group 1: Transaction Details - Webster stockholders will receive $48.75 in cash and 2.0548 Santander American Depository Shares for each Webster common share, equating to a per-share consideration of approximately $75.59 based on closing prices as of February 2, 2026 [2]. - Webster insiders are set to receive substantial benefits as part of the change of control arrangements [2]. Group 2: Investigation Focus - The transaction agreement imposes significant penalties on Webster if it accepts competing bids, which raises concerns about the board of directors' fulfillment of their fiduciary duties to all shareholders [3].

Core Viewpoint - Fermi Inc. is facing a class action lawsuit due to alleged misleading statements and failures to disclose critical information during its IPO and subsequent trading period, leading to significant stock price declines [1][3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Lupia v. Fermi Inc. and was filed in the Southern District of New York, charging Fermi and its executives with violations of the Securities Act of 1933 and the Securities Exchange Act of 1934 [1][3]. - Investors who purchased Fermi common stock during the IPO or between October 1, 2025, and December 11, 2025, can seek appointment as lead plaintiff by March 6, 2026 [1][6]. - The lawsuit alleges that Fermi overstated tenant demand for its Project Matador campus and failed to disclose reliance on a single tenant's funding commitment, which posed a significant risk [3][4]. Group 2: Financial Impact - Following the announcement that the first tenant for Project Matador terminated a $150 million funding agreement, Fermi's stock price dropped nearly 34% [4]. - The stock price has since fallen to as low as $8.59 per share, representing a 59% decline from the IPO price of $21.00 per share [5]. Group 3: Company Background - Fermi Inc. is described as an energy and AI infrastructure company, having sold 37,375,000 shares at $21.00 each during its October 2025 IPO [2][3]. - Robbins Geller Rudman & Dowd LLP, the law firm representing the investors, is noted for its significant recoveries in securities-related class action cases, having recovered over $2.5 billion for investors in 2024 alone [7].

Core Viewpoint - Richtech Robotics Inc. is facing a class action lawsuit for allegedly misleading investors about its relationship with Microsoft, which has resulted in a significant drop in its stock price [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit, titled Diez v. Richtech Robotics Inc., allows purchasers of Richtech Robotics securities between January 27, 2026, and January 29, 2026, to seek appointment as lead plaintiff by April 3, 2026 [1]. - The lawsuit alleges that Richtech Robotics falsely claimed a commercial relationship with Microsoft during the class period [3]. - Following the publication of an article by Hunterbrook Media on January 29, 2026, which denied any partnership with Microsoft, Richtech Robotics Class B stock fell over 29% within two trading days [4]. Group 2: Company Background - Richtech Robotics develops, manufactures, and sells robotic solutions aimed at automation in the service industry [2]. - Robbins Geller Rudman & Dowd LLP, the law firm representing the investors, is recognized as a leading firm in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [6].

MILWAUKEE, Feb. 2, 2026 /PRNewswire/ -- Ademi LLP is investigating Northfield (NASDAQ: NFBK) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Columbia Financial. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, Northfield stockholders will receive either shares of the new holding company or ...

Core Viewpoint - Coterra is under investigation for potential breaches of fiduciary duty related to its transaction with Devon Energy, which may not be in the best interest of its shareholders [1][3]. Group 1: Transaction Details - Coterra stockholders will receive 0.70 shares of Devon common stock for each Coterra share, resulting in Devon shareholders owning approximately 54% of the combined company and Coterra shareholders holding about 46% on a fully diluted basis [2]. - Coterra insiders are set to receive substantial benefits as part of the change of control arrangements [2]. Group 2: Investigation Focus - The transaction agreement imposes significant penalties on Coterra for accepting competing bids, which raises concerns about the board's fulfillment of fiduciary duties to all shareholders [3].

Core Viewpoint - The Ardent Health class action lawsuit alleges that the company and its executives made misleading statements regarding financial practices and liability reserves, leading to significant stock price declines following revelations of financial discrepancies [3][4]. Group 1: Allegations and Financial Impact - The lawsuit claims that Ardent Health did not accurately assess the collectability of accounts receivable, which inflated reported financial positions [3]. - On November 12, 2025, Ardent Health disclosed a $43 million decrease in third quarter 2025 revenue due to revised accounts receivable assessments, resulting in a nearly 34% drop in stock price [4]. - The company also cut its 2025 EBITDA guidance by approximately 9.6%, from a range of $575 million - $615 million to $530 million - $555 million, citing industry-wide cost pressures [4]. Group 2: Legal Process and Representation - Investors who purchased Ardent Health securities during the specified class period can seek to be appointed as lead plaintiff in the class action lawsuit [5]. - The lead plaintiff will represent the interests of all class members and can choose a law firm to litigate the case [5]. Group 3: Company Overview - Ardent Health operates a network of hospitals and clinics providing various healthcare services [2].

Core Viewpoint - The Blue Owl Capital Inc. class action lawsuit alleges that the company and its executives violated the Securities Exchange Act of 1934, with claims centered around undisclosed liquidity issues and significant pressure on its asset base due to BDC redemptions [1][3]. Group 1: Allegations and Financial Performance - The lawsuit claims that Blue Owl failed to disclose meaningful pressure on its asset base from BDC redemptions, leading to undisclosed liquidity issues [3]. - Financial results for Q3 2025 reported fee-related earnings of $376.2 million, missing consensus estimates, and performance revenue fell 33% year over year to $188,000 [4]. - Following the announcement of a merger agreement involving Blue Owl's direct lending businesses, the stock price fell nearly 5% [5]. Group 2: Impact of External Reports - An article published by Financial Times indicated that OBDC II shareholders could face a 20% reduction in investment value due to the merger, which further impacted Blue Owl's stock price, causing a nearly 6% drop [6]. Group 3: Legal Process and Representation - Investors who purchased Blue Owl securities during the class period can seek appointment as lead plaintiff in the class action lawsuit, representing the interests of all class members [7]. - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud litigation, having recovered over $2.5 billion for investors in 2024 alone [8].

Core Viewpoint - Klarna Group plc is facing a class action lawsuit related to its September 10, 2025 IPO, alleging violations of the Securities Act of 1933 due to misleading offering documents and understated risk regarding loan loss reserves [1][3]. Group 1: Class Action Lawsuit Details - The class action lawsuit, titled Nayak v. Klarna Group plc, allows purchasers of Klarna securities from the IPO to seek appointment as lead plaintiff by February 20, 2026 [1][2]. - Klarna's IPO involved the issuance of approximately 34 million shares at an offering price of $40.00 per share [2]. - The lawsuit claims that Klarna's offering documents were materially false and omitted critical information about the company's risk profile related to its buy now, pay later loans [3]. Group 2: Financial Performance and Stock Impact - Following the IPO, Klarna reported a net loss of $95 million on November 18, 2025, and increased provisions for loan losses to $235 million, exceeding analyst estimates of $215.8 million [4]. - Provisions for loan losses represented 0.72% of gross merchandise volume, up from 0.44% the previous year [4]. - By the time the class action lawsuit commenced, Klarna's stock price had fallen to as low as $31.31 per share, significantly below the IPO price of $40 [4]. Group 3: Legal Representation and Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Klarna securities during the IPO to seek lead plaintiff status in the class action lawsuit [5]. - The lead plaintiff will represent the interests of all class members and can choose a law firm to litigate the case [5]. Group 4: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [6]. - The firm has been ranked 1 in the ISS Securities Class Action Services rankings for four out of the last five years [6].

SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that Smartsheet Inc. (NYSE: SMAR) shareholders who held Smartsheet securities as of the record date, October 25, 2024, and were harmed by defendants’ alleged violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 in connection with the acquisition of Smartsheet by Blackstone Inc., Vista Equity Partners Management, LLC, as well as the Abu Dhabi Investment Authority (“Merger”), have until February 24 ...